Cara Therapeutics | CARA - Capital Ordinário

Preço das Ações
2.90
Mudança Diária
-0.06 -2.03%
Mensal
-23.28%
Anual
-80.27%
Q2 Previsão
2.82




Capital Ordinário Alterar Data
Acadia Pharmaceuticals USD 169.18M 470K 2025-12
Alterity Therapeutics Limited AUD 10.88B 10.66B 2025-12
Assertio Holdings USD 9K 0 2023-12
Cara Therapeutics USD 9.38M 9.38M 2025-09
Cassava Sciences USD 48.31M 0 2025-12
Chugai Pharma JPY 1.65B 8K 2025-12
Cipla INR 807.77M 807.43M 2025-09
Clal Biotechnology ILS 1.61M 0 2022-12
Compugen USD 94.55M 1.02M 2025-12
CSL USD 482.13M 93.87M 2025-12
Grifols EUR 680.58M 846.11K 2025-12
Halozyme Therapeutics USD 117.78M 259K 2025-12
J&J USD 2.41B 584K 2025-09
Neurocrine Biosciences USD 100.1M 400K 2025-12
Pacira USD 41.12M 1.85M 2025-12
Pfizer USD 5.69B 1000K 2025-09
RedHill Biopharma USD 33.3B 20.4B 2025-06
Supernus Pharmaceuticals USD 57.12M 1000K 2025-09
Vanda Pharmaceuticals USD 58K 0 2024-12